D-1508-2020 Class II Terminated

Recalled by Lannett Company, Inc. — Philadelphia, PA

FDA drug recall D-1508-2020 was initiated by Lannett Company, Inc. on Aug 10, 2020 and is designated Class II. Reason for recall: Labeling: Label Mix Up: bottle labeled to contain Prednisone Tablets, USP 2.5 mg actually contained Prednisone Tablets, USP 10 mg The recall status is terminated (terminated Jul 22, 2022).

Recall details

Product Type
Drugs
Report Date
Aug 26, 2020
Initiation Date
Aug 10, 2020
Termination Date
Jul 22, 2022
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Prednisone Tablets, USP 2.5 mg, 100 tablets, Rx only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, Manufactured by: Tianjin Tianyao Pharmaceuticals Co., Ltd No. 221 Huanghai Road, Tianjin Economical-Technological Development Area, Tianjin, China 300457 NDC 0527-2931-37

Reason for recall

Labeling: Label Mix Up: bottle labeled to contain Prednisone Tablets, USP 2.5 mg actually contained Prednisone Tablets, USP 10 mg

Distribution pattern

US Nationwide

Code information

Batch Number PE190701e1 with expiry June 2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1508-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1508-2020. Report a data issue: hello@regdatalab.com.